Literature DB >> 12023154

A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis.

Thomas G Shanahan1, Parashar J Nanavati, Paul W Mueller, Randy B Maxey.   

Abstract

PURPOSE: To compare preparation time, procedure time in the operating room, equipment needs, and Day 0 postimplant dosimetry between two different Mick implant techniques performed at a single institution. METHODS AND MATERIALS: One hundred consecutive monotherapy patients treated from 1999 to 2000 with 125I transperineal permanent implantation of the prostate using an afterloading Mick applicator were evaluated. The first 40 patients were treated with a preplanned modified peripheral loading Mick technique. The next 60 were treated with a hybrid interactive image-guided Mick technique. The analysis included planning the following: ultrasound volume, time required of preplanning, Day 0 CT volume, number of seeds, number of needles, activity per seed, total activity of the implant, and procedure time. Dosimetric parameters included D(90), V(100), and V(150).
RESULTS: Mean planning ultrasound volume (33 vs. 37 cc), Day 0 CT volume (49 vs. 47 cc), mCi/seed (0.30 vs. 0.34 mCi/seed), number of seeds (121 vs. 96), total activity of the implant (36 vs. 32 mCi), D(90) (132 vs. 149 Gy), V(100) (86% vs. 91%), and V(150) (51% vs. 38%) were comparable. Significant differences (p < 0.01) were noted in mean preplan time (30 vs. 7 min), number of needles (32 vs. 19), and procedure time (90 vs. 40 min).
CONCLUSIONS: Hybrid interactive Mick prostate brachytherapy consistently reduces preplanning time, procedure time, and number of needles used, reducing patient treatment time and costs while maintaining excellent dosimetric coverage. Use of hybrid interactive Mick prostate brachytherapy results in improved therapeutic ratios, i.e., maintains Day 0 D(90) >140 Gy, V(100) >90%, and V(150) <40%, without the need for sophisticated three-dimensional intraoperative planning technology.

Entities:  

Mesh:

Year:  2002        PMID: 12023154     DOI: 10.1016/s0360-3016(02)02757-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  Permanent interstitial brachytherapy for prostate cancer: a current review.

Authors:  Jeffrey Woolsey; Nicole Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 4.226

2.  Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience.

Authors:  Kana Kobayashi; Koji Okihara; Tsuyoshi Iwata; Norihiro Aibe; Naohiro Kodani; Takuji Tsubokura; Kazumi Kamoi; Tsuneharu Miki; Hideya Yamazaki
Journal:  J Radiat Res       Date:  2013-01-04       Impact factor: 2.724

Review 3.  Three-dimensional conformal brachytherapy for prostate cancer.

Authors:  Michael J Zelefsky
Journal:  Curr Urol Rep       Date:  2004-06       Impact factor: 2.862

4.  Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer.

Authors:  Hiromichi Ishiyama; Takefumi Satoh; Akane Sekiguchi; Ken-Ichi Tabata; Shouko Komori; Hideyasu Tsumura; Shogo Kawakami; Itaru Soda; Kouji Takenaka; Masatsugu Iwamura; Kazushige Hayakawa
Journal:  J Contemp Brachytherapy       Date:  2015-01-26

5.  Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis.

Authors:  Pieter Logghe; Rolf Verlinde; Frank Bouttens; Caroline Van den Broecke; Nathalie Deman; Koen Verboven; Dirk Maes; Luc Merckx
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

6.  Progressive transition from pre-planned to intraoperative optimizing seed implant: post implementation analysis.

Authors:  Hsiang-Chi Kuo; William Bodner; Ravindra Yaparpalvi; Chandan Guha; Bhupendra M Tolia; Keyur J Mehta; Dennis Mah; Shalom Kalnicki
Journal:  J Contemp Brachytherapy       Date:  2012-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.